evans blue has been researched along with edaravone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, S; Hattori, Y; Sagara, H; Takano, Y; Takashina, M; Tomita, K; Yagisita, S; Yokoo, H | 1 |
| Fang, W; Geng, X; Han, D; Li, Y; Lv, P; Sha, L; Shang, E; Wei, J; Yang, Q; Zhang, R | 1 |
2 other study(ies) available for evans blue and edaravone
| Article | Year |
|---|---|
Neurodegenerative evidence in mice brains with cecal ligation and puncture-induced sepsis: preventive effect of the free radical scavenger edaravone.
Topics: Animals; Antipyrine; Blood-Brain Barrier; Cecum; Cytokines; Edaravone; Evans Blue; Fluorescein; Free Radical Scavengers; Gene Expression Regulation; Ligation; Mice; Microscopy, Electron; NADPH Oxidases; Neurodegenerative Diseases; Nitric Oxide Synthase Type II; Phosphoproteins; Real-Time Polymerase Chain Reaction; Sepsis | 2012 |
Platelet activating factor induces transient blood-brain barrier opening to facilitate edaravone penetration into the brain.
Topics: Animals; Antipyrine; ATP Binding Cassette Transporter, Subfamily B; Blood-Brain Barrier; Blotting, Western; Brain; Brain Edema; Capillaries; Cerebrospinal Fluid; Cerebrovascular Circulation; Chromatography, High Pressure Liquid; Coloring Agents; E-Selectin; Edaravone; Endothelial Cells; Evans Blue; Flow Cytometry; Infusions, Intravenous; Male; Matrix Metalloproteinase 9; Microdialysis; Neuroprotective Agents; Platelet Activating Factor; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Serum Albumin, Radio-Iodinated; Tetrazolium Salts; Thiazoles | 2014 |